<DOC>
	<DOCNO>NCT00532116</DOCNO>
	<brief_summary>Evaluate effect age PK two different dos EMSAM .</brief_summary>
	<brief_title>PK Comparison 6mg 12mg EMSAM Elderly vs. Non-Elderly</brief_title>
	<detailed_description />
	<mesh_term>Selegiline</mesh_term>
	<criteria>1 . Male Female , 18 45years age ( inclusive ) 65 year age old . 2 . Nonobese define within 15 % desirable body weight frame size ( Appendix II ) . 3 . In general good health ascertain physical examination ( PE ) include measurement supine stand vital sign , medical history , clinical laboratory study , 12lead electrocardiogram ( ECG ) . 4 . Females must negative serum pregnancy test screening confirm negative urine pregnancy screen baseline visit . Women childbearing potential must agree continuously use medically acceptable method birth control course study . Acceptable birth control method hormonal contraceptive , intrauterine device double barrier method ( combination condom plus contraceptive foam ) . Postmenopausal females eligible participate last normal menses least one ( 1 ) year prior study entry . 5 . Able willing provide inform consent . 6 . Able willing follow modify diet . 7 . Able willing follow requirement study ; willing wear patch , swimming , excessive exercise , etc . 1 . Presence significant acute chronic medical disorder might complicate interfere MAO inhibitor therapy , : 1 . Any cardiovascular cardiac condition require drug treatment . Upon review Sponsor , subject well control hypertension hyperlipidemia allow . 2 . History symptomatic orthostatic hypotension , investigator 's best clinicaljudgment clinically significant postural decrease systolic blood pressure screen baseline . 3 . Type I diabetes mellitus , poorly control Type II diabetes mellitus . 4 . Malignancy and/or chemotherapy within 1 year prior screening , basal cell carcinoma . Malignancies 1 year may preclude participation review casebycase basis Somerset Pharmaceuticals , Inc. , medical monitor . 5 . Any skin condition ( e.g. , eczema , psoriasis , dyshydrosis ) might interfere application adherence STS . 6 . Known suspected hypersensitivity selegiline MAO inhibitor . 7 . Any significant immunological , pulmonary , hematologic , endocrine and/or metabolic disease disorder severe acute medical illness , , metastatic cancer , brain tumor , decompensated cardiac , hepatic renal failure . 8 . Neurological disorder include delirium , history head trauma , movement disorder , dementia , multiple sclerosis , stroke , within past 6 month precede study . 2 . Any central nervous system disorder include Alzheimer 's disease , Parkinson 's disease , epilepsy , cerebrovascular disease . 3 . Any psychiatric disorder ( except personality disorder ) . 4 . Any mood disorder include MDD current relapse past three year . 5 . ADHD . 6 . Any condition may cause depression include endocrinopathies diabetes , lymphoma , pancreatic cancer . 7 . Any illness disorder opinion Investigator would place subject significant risk inability follow requirement study regard maintain schedule visit patch application . 8 . Use medication list within five halflives prior baseline . A long period time may specifically note certain medication indicate : 1 . All contraindicated medication ( see Section 7.1.4.3 ) 2 . Psychotropic medication , include centrally active anticholinergic , anticonvulsant , antiparkinsonian agent , fluoxetine ( 5 week ) , MAOIs ( 2 week ) , antipsychotic ( oral 60 day ; intramuscular 10 week ) , anxiolytic , vasodilator ( exception : Viagra permit ) , cerebral enhancer ( acetylcholinesterase inhibitor ) , psychostimulants , lithium carbonate , nootropics , reserpine , methyldopa ( within 30 day ) , ergot preparation . 3 . Sympathomimetic drug , e.g. , amphetamine , methylphenidate , dopamine , epinephrine , norepinephrine , overthecounter ( OTC ) prescription nasal decongestant ( exception nasal steroid ) , oral inhale sympathomimetic bronchodilator ( e.g. , albuterol [ Proventil ] , Serevent ) appetite suppressant . 4 . Any serotonergic drug include sumatriptan succinate ( Imitrex ) , zolmitriptan ( Zomig ) , cyproheptadine ( Periactin ) , methysergide ( Sansert ) agonists antagonist serotonin receptor . 5 . Meperidine ( Demerol ) , opioids . 6 . R ( ) tryptophan , metoclopramide . 7 . St. John 's wort / hypericum within two ( 2 ) week herbal supplement 8 . Dietary supplement contain tyramine and/or ephedrine . 9 . Presence AxisII disorder make unlikely subject compliant . 10 . Presence history bipolar disorder psychotic disorder . 11 . Serious risk suicide . 12 . History substance abuse , include alcohol abuse define DSMIV criterion , within past 12 month . 13 . Current use tobacco product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Elderly</keyword>
	<keyword>Non Elderly</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>